DEREK TATUM: Open Payments
NPI 1013488246 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 20 payments from 9 companies in 2025. Trend: 2023 $118 · 2024 $135 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $345 |
| UCB, Inc. | 2 | $157 |
| Janssen Biotech, Inc. | 5 | $152 |
| Galderma Laboratories, L.P. | 1 | $139 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Incyte Corporation | 1 | $25 |
| Amgen Inc. | 1 | $24 |
| LEO Pharma Inc. | 1 | $18 |
Products named: RINVOQ, Bimzelx, TREMFYA, SKYRIZI, NEMLUVIO, ILUMYA, DUPIXENT, OPZELURA.
Industry payments across VA — which companies pay providers there.
